KIF14 has been associated with cervical cancer, and a knockdown model of KIF14 impacted the cell cycle by affecting cell viability, proliferation, and migration, thus placing it as a potential therapeutic target [70]. This evidence concerns the gene KIF14 and cervical cancer.